Insulet Corporation - Common Stock (NQ:PODD)

225.50 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2026 Add to My Watchlist

Price and Volume

Volume	3
Open	225.50
Bid (Size)	208.32 (40)
Ask (Size)	234.79 (80)
Prev. Close	225.50
Today's Range	225.50 - 225.50
52wk Range	216.49 - 354.88
Shares Outstanding	68,873,869
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 19, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Performance

YTD	-20.3%	-20.3%
1 Month	-9.6%	-9.6%
3 Month	-21.0%	-21.0%
6 Month	-31.2%	-31.2%
1 Year	-17.7%	-17.7%

More News

Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 18, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Discover the top S&P500 movers in Thursday's after-hours session. ↗

March 12, 2026

Via Chartmill

Insulet Corp (NASDAQ:PODD): A High-Growth Stock Forming a Technical Base ↗

February 25, 2026

Via Chartmill

Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 18, 2026

From Law Offices of Howard G. Smith

Via Business Wire

1 Healthcare Stock with Exciting Potential and 2 We Avoid

March 18, 2026

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

Via The Motley Fool

EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America ↗

March 14, 2026

Via Benzinga

Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 13, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 13, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Exploring the top movers within the S&P500 index during today's session. ↗

March 13, 2026

Via Chartmill

Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 13, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Friday's session: top gainers and losers in the S&P500 index ↗

March 13, 2026

Via Chartmill

Friday's session: gap up and gap down stock in the S&P500 index ↗

March 13, 2026

Via Chartmill

Top S&P500 movers in Friday's pre-market session ↗

March 13, 2026

Via Chartmill

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

March 12, 2026

From Insulet Corporation, Inc.

Via Business Wire

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

March 11, 2026

From Insulet Corporation

Via Business Wire

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

March 10, 2026

From Insulet Corporation

Via Business Wire

1 Oversold Stock Set for a Comeback and 2 Facing Challenges

February 26, 2026

Via StockStory

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 20, 2026

Via Chartmill

Friday's session: gap up and gap down stock in the S&P500 index ↗

February 20, 2026

Via Chartmill

Which S&P500 stocks are moving on Thursday? ↗

February 19, 2026

Via Chartmill

Frequently Asked Questions

Is Insulet Corporation - Common Stock publicly traded?

Yes, Insulet Corporation - Common Stock is publicly traded.

What exchange does Insulet Corporation - Common Stock trade on?

Insulet Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Insulet Corporation - Common Stock?

The ticker symbol for Insulet Corporation - Common Stock is PODD on the Nasdaq Stock Market

What is the current price of Insulet Corporation - Common Stock?

The current price of Insulet Corporation - Common Stock is 225.50

When was Insulet Corporation - Common Stock last traded?

The last trade of Insulet Corporation - Common Stock was at 03/24/26 04:00 PM ET

What is the market capitalization of Insulet Corporation - Common Stock?

The market capitalization of Insulet Corporation - Common Stock is 15.53B

How many shares of Insulet Corporation - Common Stock are outstanding?

Insulet Corporation - Common Stock has 16B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.